Synthesis and evaluation of poly (N-vinyl caprolactam)-co-tert-butyl acrylate as kinetic hydrate inhibitor

Low dosage kinetic hydrate inhibitors (KHIs) are a kind of alternative chemical additives to high dosage thermodynamic inhibitors for preventing gas hydrate formation in oil & gas production wells and transportation pipelines. In this paper, a new KHI, poly (N-vinyl caprolactam)-co-tert-butyl acrylate (PVCap-co-TBA), was successfully synthesized with N-vinyl caprolactam (NVCap) and tert-butyl acrylate. The kinetic inhibition performances of PVCap-co-TBA on the formations of both structure I methane hydrate and structure II natural gas hydrate were investigated by measuring the onset times of hydrate formation under different conditions and compared with commercial KHIs such as PVP, PVCap and inhibex 501. The results indicated that PVCap-co-TBA outperformed these widely applied inhibitors for both structure I and structure II hydrates. At the same dosage of KHI, the maximum tolerable degree of subcooling under which the onset time of hydrate formation exceeded 24 hours for structure I hydrate was much lower than that for structure II hydrate. The inhibition strength increased with the increasing dosage of PVCap-co-TBA; The maximum tolerable degree of subcooling for the natural gas hydrate is more than 10 K when the dosage was higher than 0.5% (mass) while it achieved 12 K when that dosage rose to 0.75% (mass). Additionally, we found polypropylene glycol could be used as synergist at the dosage of 1.0 % (mass) or so, under which the kinetic inhibition performance of PVCap-co-TBA could be improved significantly. All evaluation results demonstrated that PVCap-co-TBA was a very promising KHI and a competitive alternative to the existing commercial KHIs. (C) 2022 The Chemical Industry and Engineering Society of China, and Chemical Industry Press Co., Ltd. All rights reserved.

Automated summary

This paper investigated a new low dosage kinetic hydrate inhibitor (KHI), poly(N-vinyl caprolactam)-co-tert-butyl acrylate (PVCap-co-TBA), and compared its inhibition performance with commercial inhibitors. The results showed that PVCap-co-TBA outperformed other inhibitors for both structure I and structure II hydrates. Additionally, polypropylene glycol was found to significantly improve the inhibition performance of PVCap-co-TBA as a synergist.